Selected article for: "active compound and low activity"
Author: Zhou, Mengxin; Han, Yutong; Li, Mengxia; Ye, Gang; Peng, Guiqing
Title: Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus
  • Cord-id: kmoq007n
  • Document date: 2021_7_6
    • ID: kmoq007n
    Snippet: Coronaviruses (CoVs) are important human and animal pathogens that cause respiratory and gastrointestinal diseases. Porcine epidemic diarrhoea (PED), characterized by severe diarrhoea and vomiting in pigs, is a highly lethal disease caused by porcine epidemic diarrhoea virus (PEDV) and causes substantial losses in the swine industry worldwide. However, currently available commercial drugs have not shown great therapeutic effects. In this study, a fluorescence resonance energy transfer (FRET)-bas
    Document: Coronaviruses (CoVs) are important human and animal pathogens that cause respiratory and gastrointestinal diseases. Porcine epidemic diarrhoea (PED), characterized by severe diarrhoea and vomiting in pigs, is a highly lethal disease caused by porcine epidemic diarrhoea virus (PEDV) and causes substantial losses in the swine industry worldwide. However, currently available commercial drugs have not shown great therapeutic effects. In this study, a fluorescence resonance energy transfer (FRET)-based assay was applied to screen a library containing 1,590 compounds and identified two compounds, 3-(aminocarbonyl)-1-phenylpyridinium and 2,3-dichloronaphthoquinone, that target the 3C-like protease (3CL(pro)) of PEDV. These compounds are of low molecular weight (MW) and greatly inhibited the activity of this enzyme (IC(50) values were obtained in this study). Furthermore, these compounds exhibited antiviral capacity against another member of the CoV family, feline infectious peritonitis virus (FIPV). Here, the inhibitory effects of these compounds against CoVs on Vero cells and feline kidney cells were identified (with EC(50) values) and cell viability assays were performed. The results of putative molecular docking models indicate that these compounds, labeled compound 1 and compound 2, contact the conserved active sites (Cys144, Glu165, Gln191) of 3CL(pro) via hydrogen bonds. These findings provide insight into the antiviral activities of compounds 1 and 2 that may facilitate future research on anti-CoV drugs.

    Search related documents:
    Co phrase search for related documents
    • absence presence and active site residue: 1
    • absence presence and activity site: 1
    • absence presence and acute gastroenteritis: 1, 2, 3
    • absence presence and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absolute specificity and acute sars respiratory syndrome: 1, 2
    • acceptor hydrogen bond donor and active site: 1, 2, 3
    • acceptor hydrogen bond donor and acute sars respiratory syndrome: 1, 2
    • accession genbank and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • active site and acute gastroenteritis: 1, 2
    • active site and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and low micromolar range: 1, 2, 3, 4, 5, 6
    • active site residue and acute sars respiratory syndrome: 1, 2
    • activity site and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • activity site and low micromolar range: 1
    • acute gastroenteritis and additional vaccine: 1
    • acute gastroenteritis and low micromolar range: 1
    • acute sars respiratory syndrome and additional vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute sars respiratory syndrome and low micromolar range: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10